News (75)

European Midday Briefing : Stocks Gain as Bonds Track Treasuries Lower DJ
Lonza Taps Siegfried Holding's Wolfgang Wienand as Next CEO DJ
Lonza chairman to step down, drugmaker confirms targets, shares soar RE
Manufacturer Lonza says it will not fill obesity drug syringes RE
Lonza Shares Drop After Warning of 2024 Profitability Shortfall DJ
Lonza cuts 2024 margin target again after CEO departure RE
LONZA GROUP : A sudden departure Alphavalue
European Midday Briefing : Cautious Start to Week Packed with Policy Decisions DJ
European shares ease, with central banks in focus; Lonza drops on CEO exit RE
Lonza Shares Tumble After News of CEO Departure DJ
Lonza CEO Pierre-Alain Ruffieux to Leave DJ
Lonza CEO to leave by mutual agreement RE
Board Announcement EQ
Lonza Group AG Announces CEO Changes CI
Transcript : Lonza Group AG, H1 2023 Earnings Call, Jul 21, 2023
Lonza : Half-Year 2023 Results Report PU
Lonza Delivers 5.6% CER Sales Growth, With Underlying Growth at Around 10% CER and 30% CORE EBITDA Margin EQ
Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes Cell Therapies AQ
Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies BU
Transcript : Lonza Group AG, Q1 2023 Earnings Call, May 10, 2023
Q1 2023 Qualitative Update: Business Performance In Line With  Full-Year Trajectory EQ
Lonza Group Seeks Mergers and Acquisitions CI
Transcript : Lonza Group AG, 2022 Earnings Call, Jan 25, 2023
Lonza underscores growth prospects with share buy-back, dividend hike RE
Lonza : Full-Year 2022 Results Report PU
Lonza Delivers Strong 2022 Performance with 15.1% CER Sales Growth and 32.1% CORE EBITDA Margin EQ
Transcript : Lonza Group AG Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 10:30 AM
Lonza Appoints Daniel Palmacci as President of the Cell & Gene Division EQ
Transcript : Lonza Group AG, H1 2022 Earnings Call, Jul 22, 2022
Lonza Confident on 2022 Goals as 1st Half Sales Book Healthy Rise DJ
Lonza : Half-Year Results Report PU
Lonza Delivers Solid Performance in H1 2022 with 16.8% CER Sales Growth and 33.1% CORE EBITDA Margin EQ
Maria Soler Nunez appointed as Head, Group Operations EQ
Lonza to Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH) EQ
Lonza and Kodiak open custom-built bioconjugation facility AQ
Grand Opening of Kodiak Sciences Purpose-Built Bioconjugation Facility to Support Potential Commercial Manufacture of KSI-301, an Antibody Biopolymer Conjugate for Retinal Diseases AQ
Grand Opening of Kodiak Sciences' Purpose-built Bioconjugation Facility to Support Potential Commercial Manufacture of KSI-301, an Antibody Biopolymer Conjugate for Retinal Diseases PR
Lonza Group - Christian Seufert appointed as President of Capsules and Health Ingredients Division AQ
Lonza : Christian Seufert appointed as President of Capsules and Health Ingredients Division PU
Lonza : is among the 2022 World's Most Ethical Companies, as recognized by Ethisphere PU
Transcript : Lonza Group Ltd, Q4 2021 Earnings Call, Jan 26, 2022
Lonza : Full-Year Results Report PU
Lonza Delivers Strong 2021 performance with 20% CER Sales Growth EQ
Transcript : Lonza Group Ltd - Analyst/Investor Day
Lonza : Philippe Deecke appointed as Chief Financial Officer of Lonza Group PU
12NextSee all

Companies (27)

MESB 14 M $
Logo MESB

MESB Berhad is an investment holding company. The Company’s segments include Retailing, Investment holding and Waste recycling. Its Retailing segment is involved in the trading and retailing of leather products, apparel and accessories. Its retailing se ...

GO METALS CORP. 2 M $
Logo Go Metals Corp.

Go Metals Corp. is a Canada-based exploration stage company. The HSP Nickel-Copper-Cobalt Project is located approximately 130 kilometers (km) north of Havre-Saint-Pierre in Quebec and approximately 150 square kilometers property is located within the Gre ...

PIERRE & VACANCES 747 M $
Logo Pierre & Vacances

Pierre & Vacances is a leading European operator of tourist residences and villages. Net sales break down by a ctivity as follows: - operation of residences and villages (94.5%): manages, at the end of September 2023, a total of 45,866 apartments and ho ...

BIOPHARM - $
Logo BIOPHARM

Biopharm SPA is one of the leading pharmaceutical groups in Algeria. The group manufactures generic pharmaceuticals under its own brands, as well as licensed drugs for laboratories such as Sanofi, Eli Lilly and Pierre Fabre. At the end of 2022, Biopharm ...

IMMOBILIÈRE PARISIENNE DE LA PERLE ET DES PIERRES PRÉCIEUSES 1 M $
Logo Immobilière Parisienne de la Perle et des Pierres Précieuses

Immobilière Parisienne de la Perle et des Pierres Précieuses specializes in holding and managing of the building located at 38 rue Croix des Petits Champs and the building located at Avenida Nicolas de Pierola n°508-540, Esquina con la Avenida Garcilaso d ...

LALIQUE GROUP SA 258 M $
Logo Lalique Group SA

Lalique Group SA, formerly Art & Fragrance SA, is a Switzerland-based company engaged in the fragrance, crystal and jewelry industries. It designs and develops new fragrances, acquires and manages brands and license rights in the perfume and cosmetics are ...

SINCERE WATCH (HONG KONG) LIMITED 15 M $
Logo Sincere Watch (Hong Kong) Limited

Sincere Watch (Hong Kong) Limited is a Hong Kong-based investment holding company principally engaged in watch businesses. The main businesses of the Company include the distribution of branded watches, timepieces and accessories, dining businesses and pr ...

OHTL 170 M $
Logo OHTL

OHTL Public Company Limited is a Thailand-based company engaged in the hotel and restaurant business. The Company’s segments include hotel operations, food and beverage, and outside shops. The Company operates a hotel business known as Mandarin Oriental ...

GALENICA AG 3 893 M $
Logo Galenica AG

Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established ...

TRUWORTHS LIMITED - $
Logo Truworths Limited

Truworths Limited specializes in the design, manufacturing and marketing of clothes and accessories for men and women. Net sales break down by activity as follows: - retail distribution of clothes and accessories (98.6%): Nine West, Guess, Ka'yanda, Bert ...


123Next

Insiders

Pierre-Alain Ruffieux
Pierre-Alain Ruffieux

Dr. Pierre-Alain Ruffieux is a Chief Executive Officer at Lonza Group AG. Dr. Ruffieux was previously employed as a Head-Global Pharma Technical Operations by F. Hoffmann-La Roche Ltd. and a Head-Pharmaceutical Division by Novartis Pharmaceuticals Corp. He received his undergraduate degree from Swiss Federal Institute of Technology and a graduate degree from Swiss Federal Institute of Technology.



Picture Michel Ruffieux
Michel Ruffieux

Michel Ruffieux is currently working as a Vice President at Credit Suisse Entrepreneur Capital AG since 2011.
Prior to this, he worked at Credit Suisse Group AG as the General Counsel from 1992 to 2011.




Picture Serge Ruffieux
Serge Ruffieux

Serge Ruffieux has a current job as the Creative Director at Christian Dior SE.



Picture Paul Ruffieux
Paul Ruffieux

Paul Ruffieux worked as Vice President & Member-Executive Board at Skan AG in 2013.



No results for this search

  1. Stock Market
  2. Advanced search
  3. Pierre-Alain Ruffieux